Evidence map›Paper›PMID 41322855›Full record

ArticleCureus2025

Evaluation of the Flexural Strength and Translucency of Zirconia With Different Microstructures.

Merve Buse Kultas Kaleli

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Merve Buse Kultas KaleliProsthodontics, Meram Oral and Dental Health Center, Konya, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the translucency and flexural strength (FS) of three zirconia ceramics with different microstructural characteristics and to examine the relationship between these properties. MATERIALS AND

methodsZirconia specimens were prepared from IPS e.max ZirCAD Prime A2 (Ivoclar Vivadent, Schaan, Liechtenstein), Vita YZ HT (Vita Zahnfabrik, Bad Säckingen, Germany), and IPS e.max ZirCAD MT Multi A2 (Ivoclar Vivadent) blocks. A total of 30 specimens were fabricated using CAD/CAM technology with a 20% sintering shrinkage adjustment. Translucency was measured using a spectrophotometer based on the CIE L*a*b* system (Commission Internationale de l'Éclairage, Vienna, Austria), and the translucency parameter (TP) was calculated using the CIEDE2000 formula. FS was determined using a three-point bending test according to ISO 6872 standards. Statistical analysis was performed using the Kruskal-Wallis and Spearman correlation tests (p < 0.05).

resultsAlthough IPS e.max ZirCAD MT exhibited the highest translucency (p > 0.05). and Vita YZ HT showed the highest FS (p<0.05). No significant correlation was found between translucency and FS in any group.

conclusionWithin the limitations of this in vitro study, zirconia ceramics with different microstructures showed no statistically significant differences in translucency but statistically significant differences in FS.

Indexed as

flexural strengthmonolithic zirconiamultilayer zirconiaspectrophotometrytranslucency

Identifiers

PMID41322855
PMCPMC12664705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.